--- title: "Estée Lauder Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts" description: "Estée Lauder Companies Inc. is set to report its Q4 earnings on Aug. 19, projecting 27 cents per share, up from 7 cents a year ago. Analysts expect revenue of $3.83 billion, an increase from $3.63 bil" type: "news" locale: "en" url: "https://longbridge.com/en/news/211913538.md" published_at: "2024-08-19T08:04:02.000Z" --- # Estée Lauder Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts > Estée Lauder Companies Inc. is set to report its Q4 earnings on Aug. 19, projecting 27 cents per share, up from 7 cents a year ago. Analysts expect revenue of $3.83 billion, an increase from $3.63 billion last year. The company's shares fell 0.2% to close at $178.97. Recent analyst ratings reflect downgrades from multiple firms including B of A and Deutsche Bank, with price targets being cut significantly. Analysts maintain varied ratings, with accuracy rates around 62-69%. **The Estée Lauder Companies Inc**. EL is expected to release earnings results for its fourth quarter, before the opening bell on Monday, Aug. 19. Analysts expect the New York-based company to report quarterly earnings at 27 cents per share, up from 7 cents per share in the year-ago period. Estée Lauder is projected to post revenue of $3.83 billion. It reported $3.63 billion a year earlier, according to data from Benzinga Pro. Estee Lauder shares fell 0.2% to close at $94.97 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period. - **B of A Securities** analyst Bryan Spillane downgraded the stock from Buy to Neutral and cut the price target from $140 to $100 on Aug. 16. This analyst has an accuracy rate of 68%. - **Deutsche Bank** analyst Steve Powers maintained a Hold rating and lowered the price target from $132 to $108 on Aug. 9. This analyst has an accuracy rate of 68%. - **Raymond James** analyst Olivia Tong downgraded the stock from Strong Buy to Market Perform on July 22. This analyst has an accuracy rate of 69%. - **Barclays** analyst Lauren Lieberman maintained an Equal-Weight rating and slashed the price target from $136 to $117 on July 19. This analyst gas an accuracy rate of 63%. - **JP Morgan** analyst Andrea Teixeira maintained an Overweight rating and cut the price target from $145 to $129 on July 12. This analyst has an accuracy rate of 62%/ Considering buying EL stock? Here’s what analysts think: **Read This Next:** - **Jim Cramer Recommends Buying Clorox: ‘CEO Has Done Remarkable Job’** ### Related Stocks - [EL.US - Estee Lauder](https://longbridge.com/en/quote/EL.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Envestnet Asset Management Inc. Has $13.35 Million Holdings in The Estee Lauder Companies Inc. $EL | Envestnet Asset Management Inc. reduced its stake in The Estee Lauder Companies Inc. by 11.5% in Q3, holding 151,483 sha | [Link](https://longbridge.com/en/news/276105685.md) | | Balmain Beauty Introduces Destin de Balmain: A New Prestige Fragrance | Balmain Beauty has launched its first prestige fragrance, Destin de Balmain, a floral fruity eau de parfum that embodies | [Link](https://longbridge.com/en/news/276421841.md) | | BASF To Increase BDO Production In Ludwigshafen | BASF SE :BASF SUPPORTS EUROPEAN BDO SUPPLY SECURITY THROUGH INCREASED PRODUCTION IN LUDWIGSHAFEN | [Link](https://longbridge.com/en/news/276046129.md) | | Herbalife (HLF) To Report Earnings Tomorrow: Here Is What To Expect | Herbalife will report its earnings results tomorrow, with analysts expecting a revenue growth of 2.5% year-on-year to $1 | [Link](https://longbridge.com/en/news/276090591.md) | | EU says cereulide exposure risk low after baby formula recalls | The European food and disease authorities have stated that the risk of infants being exposed to cereulide toxin in baby | [Link](https://longbridge.com/en/news/276337078.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.